Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial

INTRODUCTION: Hand eczema (HE) is one of the most common skin disorders and an important cause for morbidity and occupational disability. The 1-year prevalence of HE is estimated to be up to 10% and it is estimated that 5%–7% of those develop severe chronic HE. However, current clinical evidence is...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Isabelle L, Gilberts, Rachael, Brown, Sarah, Fernandez, Catherine, Nixon, Jane, Reynolds, Catherine, Smith, Catherine, Lear, John T, Sunderland, Lesley, Green, Cathy, Goodfield, Mark, Cowdell, Fiona, Hampton, Philip, Barker, Amy, Vargas-Palacios, Armando, Tubeuf, Sandy, Wittmann, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867308/
https://www.ncbi.nlm.nih.gov/pubmed/35197358
http://dx.doi.org/10.1136/bmjopen-2021-060029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867308/
https://www.ncbi.nlm.nih.gov/pubmed/35197358
http://dx.doi.org/10.1136/bmjopen-2021-060029

Ejemplares similares